UG Healthcare Corporation Limited: Notification on Release of FY25 Financial Results

UG Healthcare Corporation Limited has issued an official notification regarding the forthcoming release of its unaudited consolidated financial results for the second half and full year ended 30 June 2025 (FY25). The announcement is scheduled to be published after market close on 28 August 2025.

Upcoming Financial Results Release

The company is currently finalizing its financial statements for FY25. Investors can access the results via the Singapore Exchange’s website or the company’s own investor relations page. No detailed financial metrics, earnings, revenue, EPS, dividend proposals, or comparative tables have been disclosed in this notification.

Investor Guidance and Caution

The Board has issued a cautionary note advising shareholders and potential investors to exercise prudence when dealing in the company’s shares. Stakeholders uncertain about their investment decisions are encouraged to consult professional advisers before trading or making investment decisions.

Corporate Governance and Sponsor’s Statement

The announcement was made with the approval of the company’s Sponsor, SAC Capital Private Limited. It is noted that the Singapore Exchange Securities Trading Limited (SGX-ST) has not examined or endorsed the contents of the announcement.

Conclusion and Investment Recommendation

Overall Financial Performance & Outlook: Given that this is a notification of results to be released at a future date, no assessment of financial performance, outlook, or trend analysis can be made at this time due to the absence of financial data or management commentary.

For Current Shareholders: Hold your position and await the detailed FY25 financial results scheduled for release on 28 August 2025. Re-evaluate your investment decision once comprehensive earnings and outlook details are available.

For Potential Investors (Non-Holders): Exercise patience and refrain from initiating a position until after the full financial results are disclosed and analyzed. This will provide a clearer basis for an informed investment decision.

Disclaimer:
This article is based solely on the information contained in the official notification. No financial data or performance metrics for FY25 have been disclosed in this document. All investment decisions should be made with consideration of the full financial report and, where needed, with advice from a qualified financial professional.

View UGHealthcare Historical chart here